BNP and betablocker therapy in chronic heart failure

被引：0
|
作者：
Jourdain, P
Funck, F
Willemard, C
Bellorini, M
Guillard, N
Loiret, J
Thebault, B
Desnos, R
机构：
[1] Ctr Hosp Rene Dubos, Pontoise, France
[2] Hop Boucicaut, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2168
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [41] Therapy of chronic left heart failure
    Ertl, G.
    Angermann, C. E.
    INTERNIST, 2007, 48 (01): : 59 - 65
  • [42] Holistic therapy of chronic heart failure
    Feldmann, C.
    Ertl, G.
    Angermann, C. E.
    INTERNIST, 2014, 55 (06): : 676 - +
  • [43] Benefits of Natriuretic Peptide Guided Heart Failure Therapy for Patients With Chronic Left Ventricular Systolic Dysfunction: Primary Results of the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
    Januzzi, James
    Rehman, Shafiq U.
    Mohammed, Asim A.
    Bhardwaj, Anju
    Barajas, Linda
    Barajas, Justine
    Kim, Han-Na
    Baggish, Aaron L.
    Weiner, Rory B.
    Chen-Tournoux, Annabel A.
    Marshall, Jane E.
    Moore, Stephanie A.
    Carlson, William
    Lewis, Gregory D.
    Shin, Jordan
    Sullivan, Dorothy
    Parks, Kimberly
    Wang, Thomas
    Gregory, Shawn A.
    Uthamalingam, Shanmugam
    Semigran, Marc J.
    CIRCULATION, 2010, 122 (21) : 2221 - 2221
  • [44] Research on the Correlation between Plasma BNP and the Condition and Prognosis of Chronic Heart Failure
    Ma, Bocong
    Zhao, Ming
    Guo, Zhihao
    Zhao, Zheng
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (06) : 274 - 280
  • [45] Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure
    Aleksova, Aneta
    Masson, Serge
    Maggioni, Aldo P.
    Lucci, Donata
    Urso, Renato
    Staszewsky, Lidia
    Ciaffoni, Stefano
    Cacciatore, Giuseppe
    Misuraca, Gianfranco
    Gulizia, Michele
    Mos, Lucio
    Proietti, Gianni
    Minneci, Calogero
    Latini, Roberto
    Sinagra, Gianfranco
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (02) : 131 - 143
  • [46] Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure
    Aneta Aleksova
    Serge Masson
    Aldo P. Maggioni
    Donata Lucci
    Renato Urso
    Lidia Staszewsky
    Stefano Ciaffoni
    Giuseppe Cacciatore
    Gianfranco Misuraca
    Michele Gulizia
    Lucio Mos
    Gianni Proietti
    Calogero Minneci
    Roberto Latini
    Gianfranco Sinagra
    Cardiovascular Drugs and Therapy, 2012, 26 : 131 - 143
  • [47] BNP and functional status in heart failure
    Hogenhuis, J
    Jaarsma, T
    Voors, AA
    van Veldhuisen, DJ
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (06) : 507 - 507
  • [48] Asymptomatic Left Ventricular Systolic Dysfunction (Stage B Heart Failure) and Response to Chronic Protein Therapy With SQ BNP
    McKie, Paul M.
    Schirger, John A.
    Cataliotti, Alessandro
    Simari, Robert A.
    Redfield, Margaret M.
    Burnett, John C.
    Chen, Horng C.
    CIRCULATION, 2013, 128 (22)
  • [49] The role of BNP testing in heart failure
    Doust, Jenny
    Lehman, Richard
    Glasziou, Paul
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (11) : 1893 - 1898
  • [50] Effect of betablocker and ACE-inhibitor therapy on prognostic value of hyponatremia in outpatients with chronic heart failure. Data from IN-CHF database
    Baldasseroni, S.
    Gonzini, L.
    Urso, R.
    Orso, F.
    Cirrincione, V.
    Cacciatore, G.
    De Bernardi, A.
    Maggioni, A. P.
    EUROPEAN HEART JOURNAL, 2007, 28 : 17 - 17
12345